Patents. Law. Pharma.

PATENT PHARMACEUTICAL CONSULTING

I am frequently retained by investors seeking insight into pending patent litigations.  Clients include buy-side analysts, sell-side analysts, hedge funds, family offices, and individual investors, among others.

  • I contextualize and educate the patent-litigation process. I assist with understanding what is important to case outcomes, as well as what is not important.

  • I provide predictive assessment of case outcomes, which is based upon our first-hand experience litigating infringement and invalidity issues before District Courts, the Federal Circuit and the Patent Office.

  • I regularly advise clients on milestone litigation events, including the outcome of an IPR (inter partes review), a Markman hearing, a summary judgment motion, a bench or jury trial decision, a Federal Circuit appeal, prospective damages and the factors affecting the likelihood of settlement.

  • I understand that the timing of a court decision can be just as important as the outcome of that decision. I have developed unique methods for predicting the timing of litigation events.

  • I regularly attend court hearings and trials and provide real-time analysis from the courtroom.

  • Work-product ranges from written reports to oral presentations to on-demand conference calls. 

I have consulted or published on patent issues related to the following select pharmaceutical drugs and related technologies:

Galafold® (Amicus Therapeutics, $FOLD)
Voxzogo® (Biomarin, $BMRN)
Moderna Covid Vaccine ($MRNA)
Pfizer Covid Vaccine ($PFE)
Rezdiffra (Madgrigal, $MDGL)
Ohtuvayre®(Verona, $VRNA)
Vyndamax®, Vyndaqel® (Pfizer, $PFE)
Keytruda® (Merck, $MRK)
Nuplazid® (Acadia, $ACAD)
Exparel® (Pacira, $PCRX)
Auvelity® (Axsome, $AXSM)
Ozempic®, Wegovy®, Rybelsus® (Novo Nordisk, $NVO)
KarXT® (Bristol Meyers, $BMY)
Entresto® (Novartis, $NVS)
Imbruvica® (Pharmacyclics, $ABBV)
Cabometyx® (Exelixis, $EXEL)
Vascepa® (Amarin, $AMRN)
Gilenya® (Novartis, $NVS)
Biktarvy® (Gilead, $GILD)
Humira® (AbbVie, $ABBV)
Revlimid® (Celgene, $CELG)
Repatha® (Amgen, $AMGN)
Praluent® (Regeneron, $REGN/Sanofi, $SNY)
Remicade® (Janssen, $JNJ)
Enbrel® (Amgen, $AMGN)
Xyrem® (Jazz Pharmaceuticals, $JAZZ)
Treanda® (Teva, $TEVA)
Cubicin® (Cubist, $CBST)
Angiomax® (The Medicines Company, $MDCO)
Gralise® (Depomed, $DEPO)
Neupogen® (Amgen, $AMGN)
Neulasta® (Amgen, $AMGN)
Sovaldi® (Gilead, $GILD)
Korlym® (Corcept Therapeutics, $CORT)
Dupixent® (Regeneron, $REGN)
Eylea® (Novartis, $NVS)
Restasis® (Allergan, $AGN)
Avastin® (Roche)
Herceptin® (Roche)
Rituxan® (Roche)
Yescarta® (Gilead, $GILD)
Darzalex® (Janssen, $JNJ)
Ajovy® (Teva, $TEVA)
Aimovig® (Amgen, $AMGN)
Emgality® (Eli Lill, $LLY)
CRISPR-Cas9